Abstract: A computer-implemented method of generating fuel price data for at least one fuel type of a plurality of fuel types, the method being implemented in a computer comprising a memory in communication with a processor. The method comprises receiving, as input to the processor, unassigned delivery capacity data, the unassigned delivery capacity data indicating delivery capacity available for any one of the plurality of fuel types, receiving, as input to the processor, assigned delivery capacity data, the assigned delivery capacity data indicating, for each fuel type of the plurality of fuel types, delivery capacity only available for the fuel type of the plurality of fuel types and processing, by the processor, the assigned delivery capacity data and the unassigned delivery capacity data to generate the fuel price data for the at least one fuel type.

Abstract: A computer-implemented method of selecting a fuel type for a retail fuel site, the method being implemented in a computer comprising a memory in communication with a processor. The method comprises receiving, as input to the processor, data indicating a relationship between fuel price and fuel sales for a plurality of fuel types and receiving, as input to the processor, data indicating a property of the retail fuel site. The data indicating a relationship between fuel price and fuel sales for each of the plurality of fuel types is processed by the processor and the data indicating a property of the retail fuel site to select the fuel type for the retail fuel site.

Abstract: A computer-implemented method of generating fuel price data for a retail fuel site, the method being implemented in a computer comprising a memory in communication with a processor. The method comprises receiving, as input to the processor, data indicating a relationship between fuel sales and store sales at said retail fuel site and receiving, as input to the processor, data indicating a relationship between fuel price and fuel sales at said retail fuel site. The data indicating a relationship between fuel sales and store sales at said retail fuel site and said data indicating a relationship between fuel price and fuel sales at said retail fuel site are processed by the processor to generate said fuel price data.

Abstract: A computer-implemented method of generating fuel price data for each of a plurality of associated retail fuel sites, the method being implemented in a computer comprising a memory in communication with a processor. The method comprises receiving, as input to the processor, a total volume fuel sales target for the plurality of associated retail fuel sites and processing, by the processor, the total volume fuel sales target for the plurality of associated retail fuel sites to generate volume fuel sales targets for each of the plurality of associated retail fuel sites. The volume fuel sales targets for each of the plurality of associated retail fuel sites is processed, by the processor, to generate the fuel price data.

Abstract: The present disclosure provides non-naturally occurring polyphenol compounds that upregulate the expression of Apolipoprotein A-I (ApoA-I). The disclosed compositions and methods can be used for treatment and prevention of cardiovascular disease and related disease states, including cholesterol or lipid related disorders, such as, e.g., atherosclerosis.

Abstract: The present disclosure provides non-naturally occurring polyphenol compounds that upregulate the expression of Apolipoprotein A-I (ApoA-I). The disclosed compositions and methods can be used for treatment and prevention of cardiovascular disease and related disease states, including cholesterol or lipid related disorders, such as, e.g., atherosclerosis.

Abstract: The present disclosure provides non-naturally occurring polyphenol compounds that upregulate the expression of Apolipoprotein A-I (ApoA-I). The disclosed compositions and methods can be used for treatment and prevention of cardiovascular disease and related disease states, including cholesterol or lipid related disorders, such as, e.g., atherosclerosis.

Abstract: The present disclosure provides non-naturally occurring polyphenol compounds that upregulate the expression of Apolipoprotein A-I (ApoA-I). The disclosed compositions and methods can be used for treatment and prevention of cardiovascular disease and related disease states, including cholesterol or lipid related disorders, such as, e.g., atherosclerosis.

Abstract: The present disclosure provides non-naturally occurring polyphenol compounds that upregulate the expression of Apolipoprotein A-I (ApoA-I). The disclosed compositions and methods can be used for treatment and prevention of cardiovascular disease and related disease states, including cholesterol or lipid related disorders, such as, e.g., atherosclerosis.

Abstract: The present disclosure provides non-naturally occurring polyphenol compounds that upregulate the expression of Apolipoprotein A-I (ApoA-I). The disclosed compositions and methods can be used for treatment and prevention of cardiovascular disease and related disease states, including cholesterol or lipid related disorders, such as, e.g., atherosclerosis.

Abstract: The present disclosure relates to compounds, which are useful for regulating the expression of apolipoprotein A-I (ApoA-I), and their use for treatment and prevention of cardiovascular disease and related disease states, including cholesterol- or lipid-related disorders, such as, for example, atherosclerosis.

Abstract: Compounds and methods are provided for treating patients suffering from health condition associated with an expression state of a gene such as fertility disorders, cancer, proliferative diseases, vascular diseases, wounds requiring therapeutic intervention, inflammation, and pulmonary disorders by administering to said patient a compound capable of modulating egr-1 and/or an egr-1 response element consensus sequence thereby altering the expression state of said gene. Also described are new methods for screening compounds to identify effectors of egr-1 and/or egr-1 consensus sequence elements and methods for treating patients by administering such effectors to modulate egr-1 and/or egr-1 consensus sequences to thereby modify expression of genes associated therewith to in turn treat diseases or other physiological conditions associated with such gene expression.

Abstract: A computer implemented method for displaying values for an output variable. The method comprises: displaying a first user interface element configured to present values of a first input variable; displaying a second user interface element configured to present values of a second input variable; displaying a third user interface element configured to present values of an output variable, said output variable varying in dependence upon said first and second input variables; receiving first user input of a value for said first variable via said first user interface element; receiving second user input of a value for said second variable via said second user interface element; and updating said third user interface element to indicate at least one value of said output variable in response to said first user input and said second user input.

Abstract: The present disclosure provides non-naturally occurring polyphenol compounds that upregulate the expression of Apolipoprotein A-I (ApoA-I). The disclosed compositions and methods can be used for treatment and prevention of cardiovascular disease and related disease states, including cholesterol or lipid related disorders, such as, e.g., atherosclerosis.

Abstract: The present disclosure provides non-naturally occurring polyphenol compounds that upregulate the expression of Apolipoprotein A-I (ApoA-I). The disclosed compositions and methods can be used for treatment and prevention of cardiovascular disease and related disease states, including cholesterol or lipid related disorders, such as, e.g., atherosclerosis.

Abstract: Compounds and methods are provided for treating patients suffering from any of hypercholesterolemia, vascular oxidative stress and endothelial dysfunction.

Abstract: Compounds comprising nitric oxide derivatives of stilbenes, polyphenols and flavonoids and methods of their use are provided for treating patients suffering from any of hypercholesterolemia, vascular oxidative stress and endothelial dysfunction.

Abstract: A method, apparatus, and article of manufacture for monitoring and controlling computer systems. The invention provides an intelligent card and a monitoring and control unit coupled to the intelligent card. The intelligent card translates a data stream form a host computer system into a universal data stream. The universal data stream is communicated to the monitoring and control unit via a standard network protocol for performing operations based on the universal data stream.

Abstract: This invention relates to an improved sign which may be quickly and easily detachably secured to an automobile body by being inserted into the space between the trunk lid or front hood and the fenders of the automobile. The flat rigid sign is between 1/8 and 3/8 inches in thickness and may be formed of a corrugated cardboard panel sandwiched between two flat cardboard panels and covered by a smooth vinyl coating to be resilient to pressure from the side. It is attached to the automobile by being manually depressed into the vertical space until its lower edge abuts on a horizontal portion of one of the members forming the space, in which position it is retained substantially vertically by being resiliently engaged between the sides of the space. In a preferred embodiment, the sign has a flexible lower edge portion provided by the vinyl covering extending downward beneath the cardboard panels, which is bent sideways to engage one of the members defining the space.